` COV (Covalon Technologies Ltd) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

COV
vs
S
S&P TSX Composite Index (Canada)

Over the past 12 months, COV has underperformed S&P TSX Composite Index (Canada), delivering a return of 0% compared to the S&P TSX Composite Index (Canada)'s +21% growth.

Stocks Performance
COV vs S&P TSX Composite Index (Canada)

Loading
COV
S&P TSX Composite Index (Canada)
Add Stock
www.alphaspread.com

Performance Gap
COV vs S&P TSX Composite Index (Canada)

Loading
COV
S&P TSX Composite Index (Canada)
Difference
www.alphaspread.com

Performance By Year
COV vs S&P TSX Composite Index (Canada)

Loading
COV
S&P TSX Composite Index (Canada)
Add Stock

Competitors Performance
Covalon Technologies Ltd vs Peers

S&P TSX Composite Index (Canada)
COV
ABBV
AMGN
GILD
VRTX
Add Stock

Covalon Technologies Ltd
Glance View

Market Cap
72.1m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.72 CAD
Undervaluation 3%
Intrinsic Value
Price
Back to Top